Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 233INDUSTRY 93NETWORK 11NIH 5OTHER_GOV 1INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Proflavine 4Microbial Collagenase 2sargramostim 1pembrolizumab 1pegfilgrastim 1macimorelin 1keyhole-limpet hemocyanin 1Sodium Chloride 1Sirolimus 1Peptides 1Monatide (IMS 3015) 1Ipilimumab 1Gemcitabine 1Everolimus 1Biological Products 1Bimatoprost 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × INDIV × Everolimus × Clear all
NCT00775073 2012-04-30

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Treiber, Gerhard

Phase 2 Completed
33 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡